Serine protease inhibitors to treat inflammation: a patent review (2011-2016)

Feryel Soualmia 1 Chahrazade El Amri 1, *
* Auteur correspondant
1 VCII - Vieillissement Cellulaire Intégré et Inflammation
B2A - Adaptation Biologique et Vieillissement = Biological Adaptation and Ageing
Abstract : Introduction: Inflammation is a physiological part of the complex biological response of tissues to counteract various harmful signals. This process involves diverse actors such as immune cells, blood vessels, and nerves as sources of mediators for inflammation control. Among them serine proteases are key elements in both physiological and pathological inflammation. Areas covered: Serine protease inhibitors to treat inflammatory diseases are being actively investigated by various industrial and academic institutions. The present review covers patent literature on serine protease inhibitors for the therapy of inflammatory diseases patented between 2011 and 2016. Expert opinion: Serine proteases regulating inflammation are versatile enzymes, usually involved in proinflammatory cytokine production and activation of immune cells. Their dysregulation during inflammation can have devastating consequences, promoting various diseases including skin and lung inflammation, neuroinflammation, and inflammatory arthritis. Several serine proteases were selected for their contribution to inflammatory diseases and significant efforts that are spread to develop inhibitors. Strategies developed for inhibitor identification consist on either peptide-based inhibitor derived from endogenous protein inhibitors or small-organic molecules. It is also worth noting that among the recent patents on serine protease inhibitors related to inflammation a significant number are related to retinal vascular dysfunction and skin diseases.
Type de document :
Article dans une revue
Expert Opinion on Therapeutic Patents, Informa Healthcare, A Paraître, 〈10.1080/13543776.2018.1406478〉
Liste complète des métadonnées

http://hal.upmc.fr/hal-01656928
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : mercredi 6 décembre 2017 - 11:13:47
Dernière modification le : jeudi 11 janvier 2018 - 02:09:19

Fichier

 Accès restreint
Fichier visible le : 2018-05-24

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Feryel Soualmia, Chahrazade El Amri. Serine protease inhibitors to treat inflammation: a patent review (2011-2016). Expert Opinion on Therapeutic Patents, Informa Healthcare, A Paraître, 〈10.1080/13543776.2018.1406478〉. 〈hal-01656928〉

Partager

Métriques

Consultations de la notice

19